Medify Solutions Limited Announces Dividend

Stafford, England, November 22 (ots/PRNewswire) - Medify Solutions
Limited (OTC - MDFY), today announced that due to the achievement of
major performance milestones and the positive circumstances created
by the significant NHS developments, the company is issuing a 1 for
4 (25%) share dividend. This is also in recognition by the board
that the activities announced to shareholders in June 2006 relating
to subsidiary floatation (and associated dividend) are currently
suspended. The subsidiary floatation status is unchanged from the
most recently issued Quarterly Report.

The dividend is valid for all individuals holding shares in
MDFY.pk as per the Medify Solutions Limited Shareholders of record at
5pm Eastern Standard Time on the 30th November 2006. The dividend
will be paid in MDFY.pk shares, (electronically if available for
shareholders trading accounts), viathe company transfer agent,
Fidelity Transfer on the 15th December 2006.

To clarify, for every 4 shares held by a shareholder at 5pm 30th
November2006, a dividend of 1 share will be issued (by the Company)
to that shareholder on 15th December 2006.

It is the decision of the Board that the restricted stock issued
to the management team during September 2006 will not be eligible for
this dividend.

Ian O'Reilly, CEO of Medify Solutions, Ltd., commented to
shareholders: "given the major step changes we are seeing in the
business and the impending announcements from the NHS, the board
feels that this course of action is the correct response to our
shareholders who continue to invest in the Company".

This news release contains forward-looking statements that are
subject to certain risks and uncertainties that may cause actual
results to differ materially from those projected on the basis of
such forward-looking statements. The words "estimate", "project",
"intends", "expects", "believes", and similar expressions are
intended to identify forward-looking statements. Such
forward-looking statements are made based on management's beliefs,
as well as assumptions made by, and information currently available
to, management pursuant to the "safe-harbour" provisions of the
Private Securities Litigation Reform Act of 1995. For a more
complete description of these and other risk factors that may affect
the future performance of Medify Solutions Limited, see "Risk
Factors" in the Company's Annual Report on Form 10-KSB and its other
filings with the Securities and Exchange Commission. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date made and the Company
undertakes no obligation to disclose any revision to these
forward-looking statements to reflect events or circumstances after
the date made or to reflect the occurrence of unanticipated events.

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information: Press Office email:
press@medifysolutions.com; General email:
enquiries@medifysolutions.com; Fidelity Transfer: +1-801-484-7222;
More information at: www.medifysolutions.com